We are live on ! Find out more
BDSI

BioDelivery Sciences International, Inc.
BDSI

Delisted

BDSI was delisted on the 22nd of March, 2022.

Back to rankings

62 hedge funds and large institutions have $73M invested in BioDelivery Sciences International, Inc. in 2017 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 25 increasing their positions, 11 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

127% more repeat investments, than reductions

Existing positions increased: 25 | Existing positions reduced: 11

43% more call options, than puts

Call options by funds: $465K | Put options by funds: $326K

14% more capital invested

Capital invested by funds: $64.3M → $73M (+$8.7M)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

7% less funds holding

Funds holding: 67 → 62 (-5)

40% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 10

Holders
62
Holders Change
-5
Holders Change %
-7.46%
% of All Funds
1.55%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
6
Increased
25
Reduced
11
Closed
10
Calls
$465K
Puts
$326K
Net Calls
+$139K
Net Calls Change
+$20K

Top Buyers

Rank Fund Capital Flow
1
RA
Royce & Associates
New York
+$3.94M
2
SCM
Stonepine Capital Management
Oregon
+$1.19M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$1.09M
4
EI
EAM Investors
California
+$911K
5
Bank of Montreal
Bank of Montreal
Ontario, Canada
+$755K

Top Sellers

Rank Fund Capital Flow
1
BC
Broadfin Capital
New York
-$2.17M
2
Ameriprise
Ameriprise
Minnesota
-$1.42M
3
GCP
GSA Capital Partners
United Kingdom
-$244K
4
DCM
Driehaus Capital Management
Illinois
-$183K
5
BSW
Buckingham Strategic Wealth
Missouri
-$100K
Name Holding Trade Value Shares
Change 		Change in
Stake
HAG
26
HighPoint Advisor Group
Illinois
$359K +$34.4K +11,300 New
SKK
27
Shepherd Kaplan Krochuk
Massachusetts
$248K – – –
Citadel Advisors
28
Citadel Advisors
Florida
$222K +$186K +61,149 +436%
ARTA
29
A.R.T. Advisors
New York
$210K +$136K +44,700 +167%
NFG
30
Next Financial Group
Texas
$171K +$36.1K +11,850 +25%
Janney Montgomery Scott
31
Janney Montgomery Scott
Pennsylvania
$160K -$53.9K -17,702 -25%
State Street
32
State Street
Massachusetts
$152K – – –
SIM
33
Sterling Investment Management
Arizona
$148K – – –
Bank of New York Mellon
34
Bank of New York Mellon
New York
$131K – – –
AG
35
Advisor Group
Arizona
$126K -$7.12K -2,337 -5%
ACS
36
Archford Capital Strategies
Illinois
$118K – – –
JP Morgan Chase
37
JP Morgan Chase
New York
$116K +$120K +39,467 New
CCB
38
Cutter & Co Brokerage
Missouri
$114K -$14.5K -4,770 -11%
VNA
39
Valley National Advisers
Pennsylvania
$111K – – –
Wells Fargo
40
Wells Fargo
California
$105K +$62.7K +20,599 +138%
T. Rowe Price Associates
41
T. Rowe Price Associates
Maryland
$93K – – –
VF
42
Virtu Financial
New York
$78K +$81K +26,601 New
CAM
43
Close Asset Management
United Kingdom
$53K +$19.8K +6,500 +57%
SIC
44
Salem Investment Counselors
North Carolina
$51K – – –
UBS Group
45
UBS Group
Switzerland
$45K +$1.61K +528 +4%
SPC
46
Sigma Planning Corp
Michigan
$43K +$4.91K +1,613 +13%
CPIG
47
Chicago Partners Investment Group
Illinois
$26K -$26.6K -8,725 -50%
LTFS
48
Ladenburg Thalmann Financial Services
Florida
$19K +$9.14K +3,000 +88%
FCMT
49
Founders Capital Management (Texas)
Texas
$18K – – –
IA
50
IFP Advisors
Florida
$12K – – –
1
2
3

BDSI Hedge Fund Activity: Q3 2017 in Review

62 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in BioDelivery Sciences International, Inc. (BDSI) for Q3 2017, worth a combined $73M — up 14% from $64.3M a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of BDSI and 6 opened new positions — a net loss of 4 holders — while 11 trimmed existing stakes and 25 added.

The largest buyer was Royce & Associates, opening a new position worth an estimated $3.94M. The largest seller was Broadfin Capital, cutting an estimated $2.17M.

  • 62 institutional investors held BioDelivery Sciences International, Inc. (BDSI) as of Q3 2017, down from 67 in Q2 2017.
  • Funds reported $73M of BioDelivery Sciences International, Inc. stock for Q3 2017, up 14% quarter-over-quarter.
  • 6 funds opened new BioDelivery Sciences International, Inc. positions in Q3 2017 and 10 closed out, a net change of -4 holders.
  • The largest BioDelivery Sciences International, Inc. buyer in Q3 2017 was Royce & Associates, an estimated $3.94M added.
  • The largest BioDelivery Sciences International, Inc. seller in Q3 2017 was Broadfin Capital, an estimated $2.17M sold.

Based on aggregated 13F filings for Q3 2017.